TrovaGene to Buy MultiGen's CLIA Lab to Bolster Infectious Disease Testing Genetic Engineering News The firm says it has achieved proof-of-principle for candidate markers in infectious disease testing, cancer detection and monitoring, organ transplant rejection monitoring, and noninvasive prenatal genetic testing. Its initial focus is on the ... |
